MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival (Q28190315)
Jump to navigation
Jump to search
scientific article (publication date: August 2003)
Language | Label | Description | Also known as |
---|---|---|---|
English | MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival |
scientific article (publication date: August 2003) |
Statements
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival (English)
Bei Zheng
Paolo Fiumara
Yang V Li
Georgios Georgakis
Virginia Snell
Mamoun Younes
Jean Nicolas Vauthey
10 April 2003
Identifiers
2 references
2 references